Page last updated: 2024-10-17

n(1)-methylnicotinamide and Cancer of Liver

n(1)-methylnicotinamide has been researched along with Cancer of Liver in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ladep, NG1
Dona, AC1
Lewis, MR1
Crossey, MM1
Lemoine, M1
Okeke, E1
Shimakawa, Y1
Duguru, M1
Njai, HF1
Fye, HK1
Taal, M1
Chetwood, J1
Kasstan, B1
Khan, SA1
Garside, DA1
Wijeyesekera, A1
Thillainayagam, AV1
Banwat, E1
Thursz, MR1
Nicholson, JK1
Njie, R1
Holmes, E1
Taylor-Robinson, SD1

Other Studies

1 other study available for n(1)-methylnicotinamide and Cancer of Liver

ArticleYear
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:4

    Topics: Acetylcarnitine; Adolescent; Adult; Africa, Western; Aged; Aged, 80 and over; alpha-Fetoproteins; Bi

2014